| scholarly article | Q13442814 |
| P50 | author | Peng Chen | Q57340032 |
| P2093 | author name string | Lin Zhang | |
| Peng Zhang | |||
| Bin Zhou | |||
| Kui Zhang | |||
| Yaping Song | |||
| Zhu Zhang | |||
| Yan Pu | |||
| P2860 | cites work | Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor | Q24336391 |
| Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival | Q24612868 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide | Q28575740 | ||
| The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells | Q28594408 | ||
| Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1 | Q29619241 | ||
| Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer | Q30714393 | ||
| A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization | Q30827759 | ||
| RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin | Q34377294 | ||
| Lung cancer signature biomarkers: tissue specific semantic similarity based clustering of digital differential display (DDD) data | Q34466055 | ||
| Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans | Q34768535 | ||
| The present and future burden of urinary bladder cancer in the world | Q34945758 | ||
| Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy | Q35109085 | ||
| The health economics of bladder cancer: a comprehensive review of the published literature. | Q35642541 | ||
| Nampt: linking NAD biology, metabolism and cancer | Q37334248 | ||
| The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer | Q37661186 | ||
| Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. | Q37859970 | ||
| Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil | Q39509326 | ||
| NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response | Q39642626 | ||
| Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner | Q39795774 | ||
| NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway | Q39889099 | ||
| Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress | Q39938306 | ||
| FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis | Q40617327 | ||
| Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group | Q43794221 | ||
| Gene expression profile associated with response to doxorubicin-based therapy in breast cancer | Q46769406 | ||
| Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer | Q47832371 | ||
| PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value | Q48951220 | ||
| Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges. | Q53265518 | ||
| Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. | Q53300738 | ||
| Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. | Q53573962 | ||
| Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials | Q64112022 | ||
| A study comparing various noninvasive methods of detecting bladder cancer in urine | Q77711384 | ||
| Contemporary management of stage T1 transitional cell carcinoma of the bladder | Q77816685 | ||
| Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis | Q80234311 | ||
| Cancer incidence in five continents. Volume IX | Q83707877 | ||
| P433 | issue | 5 | |
| P921 | main subject | niacinamide | Q192423 |
| P304 | page(s) | 507-513 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | Croatian Medical Journal | Q15750362 |
| P1476 | title | Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer | |
| P478 | volume | 55 |
| Q28069876 | Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine |
| Q36057124 | High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients |
| Q38836121 | Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities |
| Q35942178 | Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer. |
| Q89640435 | Relationship between NAMPT/PBEF/visfatin and prognosis of patients with malignant tumors: a systematic review and meta-analysis |
| Q89471669 | Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level |
| Q38919116 | The Masters of the Bolognese Orthopaedic School |
Search more.